When Denmark speaks, Europe listens – life science play a key role in 2025

AMR Conference and Revision of the Pharmaceutical Package – Denmark’s EU Presidency Will Be Crucial for Danish Life Science

Denmark took over the EU Presidency on July 1, with priorities including the green transition, competitiveness, and security. Life science will also be a key focus, as Denmark assumes the EU Presidency at a critical moment for the European life science industry.

05.08.2025

Denmark’s EU Presidency opens the door to crucial trilogue negotiations between the Council, the Parliament, and the Commission on the pharmaceutical package. The legislation hasn’t been substantially updated in 20 years, so the outcome will have major consequences for the European – and Danish – life science industry.

Revisions to the Medical Device Regulation and the new Critical Medicines Act, designed to secure supplies of essential medicines and equipment, are also expected to be on the table.

All in all, Denmark’s EU Presidency will cover a wide agenda – as reflected in its official program.

Pharmadanmark and the Danish AMR Alliance during the Presidency

Antimicrobial resistance (AMR) is one of the world’s greatest health threats, already causing 1.3 million deaths every year. The burden is heaviest in developing countries, but the EU and EEA also feel the impact. In fact, AMR is responsible for an additional 568 million hospital days in Europe each year. This is a threat that knows no borders – making it both a European and global challenge that requires strong Danish as well as international action.

That is why the Danish AMR Alliance – co-founded by Pharmadanmark, the Novo Nordisk Foundation, and Pfizer – is pleased to see AMR high on the agenda during Denmark’s EU Presidency.

On 19–20 November, the Danish AMR Alliance will host a two-day conference on antimicrobial resistance (AMR), together with the Ministry of the Interior and Health, Aarhus University Hospital, and the European University Hospital Alliance. The event will look at how AMR affects hospitals and patients and focus on practical solutions – from preventing infections to ensuring future access to life-saving medicines.

At Pharmadanmark, we are proud that the AMR conference we are organizing under the Alliance has become part of the official EU Presidency program. It brings this crucial issue onto the European stage. Denmark can play a strong role in addressing AMR, but since the challenge is international, lasting solutions must be developed at the European level.

You can find an overview of the EU Presidency events, including the Danish AMR Alliance conference, here: https://danish-presidency.consilium.europa.eu/en/events/?StartDate=2025-11-19&EndDate=2025-11-20